Efficiency and Safety of Pleural Biopsy Methods in the Diagnosis of Pleural Diseases
NCT ID: NCT03153501
Last Updated: 2017-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
164 participants
INTERVENTIONAL
2011-02-08
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this prospective study, the investigators aimed to compare CT-scan guided pleural biopsy using an Abrams' needle (CT-ANPB) with US-assisted pleural biopsy using a cutting needle (US-CNPB)and medical thoracoscopy with respect to both diagnostic yield and safety.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasonography Guided Pleural Biopsy Versus Computed Tomography Guided Pleural Biopsy
NCT01196585
Image-guided Pleural Biopsy or Medical Thoracosocopy in Diagnosis of Pleural Disease
NCT05428891
Image-Guided Pleural Needle Biopsy in Pleural Diseases
NCT06541470
Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy
NCT00720954
Role of Ultrasound Guided Peripheral Thoracic Tumors
NCT04741958
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic arm
Patients with pleural diseases; malignant pleural diseases, tuberculous pleurisy, and other exudate required CT-guided Abrams needle biopsy, US-guided cutting needle biopsy, and medical thoracoscopy.
CT-guided Abrams needle biopsy, US-guided cutting needle, medical thoracoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT-guided Abrams needle biopsy, US-guided cutting needle, medical thoracoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir Osmangazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muzaffer Metintas
Medical Faculty, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muzaffer Metintas, MD
Role: PRINCIPAL_INVESTIGATOR
ESOGU Medical Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ESOGU Medical Faculty Department of Chest Diseases
Eskişehir, Meselik - Eskisehir, Turkey (Türkiye)
Eskisehir Osmangazi University Medical Faculty
Eskişehir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim SJ, Choi SM, Lee J, Lee CH, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Park YS. Medical Thoracoscopy in Pleural Disease: Experience from a One-Center Study. Tuberc Respir Dis (Seoul). 2017 Apr;80(2):194-200. doi: 10.4046/trd.2017.80.2.194. Epub 2017 Mar 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR-11-01-31-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.